Biotech Stocks Growth Stocks Healthcare Stocks Life Sciences Mid Cap Stocks Small Caps Stocks

ASX Biotech Investing In 2026: Investors Are More Aware Of The Hard Lessons, But Have Forgotten The Hidden Rewards Of It

ASX Biotech Investing has always been the market’s most difficult arena. Yes tech and resources are risky spaces too, but at least a gold explorer can gain just off the…

ByNick Sundich

01

Apr 2026

Basic Materials Biotech Stocks Blue Chip Stocks Defence Stocks Education Education Stocks Financials Large Caps Mid Cap Stocks Mining Stocks Oil and Gas Stocks Property Resources Safe Stocks Semiconductor stocks Small Caps Stocks Tech Stocks Technology

Here are 7 ASX 200 Stocks Winning During The Iran War…And Aren’t In The Soaring Oil and Gas Space!

Investors asked to name ASX 200 stocks winning during the Iran war would likely think of oil and gas stocks, benefiting from soaring prices. This is not incorrect - oil…

ByNick Sundich

16

Mar 2026

Biotech Stocks Healthcare Stocks Life Sciences

Here are 5 ASX Biotech Targets Amidst The $230bn Patent Cliff; And Which Big Pharma Companies Could Buy Them!

There are plenty of ASX Biotech Targets that major pharmaceutical companies wanting to minimise the impact of the Patent Cliff could look at. For those who don't know what the patent…

ByNick Sundich

22

Dec 2025

Healthcare Stocks Tech Stocks Technology

Is Telix Pharmaceuticals (ASX:TLX) Now Undervalued With Phase 3 China Clinical Success?

Why Telix Pharmaceuticals Pullback Could Be a Second Chance Telix Pharmaceuticals (ASX:TLX) has faced a challenging year, particularly for a company that previously delivered consistently strong growth. Disclosure issues and…

ByCharlie Youlden

09

Sep 2025

Healthcare Stocks Tech Stocks Technology

Telix Pharmaceuticals (ASX:TLX) Gets FDA Green Light to Resubmit — What Investors Should Know

Telix Pharmaceuticals Gains FDA Clarity on Glioma Imaging Agent Telix Pharmaceuticals (ASX: TLX) has given investors reason to sit up and take notice. The company announced it has reached agreement…

ByCharlie Youlden

02

Sep 2025

Bank Stocks Basic Materials Blue Chip Stocks Consumer Copper Stocks Dividend Stocks Energy Stocks ETF Financials Gold Stocks Healthcare Stocks Industrials Iron Ore Stocks Large Caps Life Sciences Lithium Stocks Mining Stocks Penny Stocks Property Rare Earths Stocks Resources Retail Semiconductor stocks Small Caps Stocks Tech Stocks Technology Uranium Stocks

ASX stocks in America: Here are 4 performing well and 4 performing poorly

You might think ASX stocks in America are doing better than peers which are not there because the USA is a much bigger market. In reality, this is not always…

ByNick Sundich

21

Aug 2025

Healthcare Stocks

Is the Market Missing Telix’s Long-Term Potential after 63% Revenue Growth?

Telix Pharmaceuticals: Controversy, Growth, and the Road Ahead Every investor knows the uneasy feeling of watching a stock fall, not because of poor earnings, but because of controversy. That is…

ByCharlie Youlden

18

Aug 2025

Healthcare Stocks International Stocks

ASX Health Care Stocks Under Trump: Who’ll Win and Who’ll Lose?

What does the next few years hold for ASX Health Care Stocks Under Trump? There's no doubt that the health care sector is bearing a greater brunt than any other…

ByNick Sundich

24

Apr 2025

Healthcare Stocks

Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!

What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful story? It would have been possible believe back in those…

ByNick Sundich

24

Dec 2024

Blue Chip Stocks

5 ASX stocks with the highest PE multiples and 5 ASX stocks with the lowest PE multiples!

5 ASX stocks with the highest PE multiples Note: All figures are in AUD and for FY25 unless otherwise stated Polynovo (ASX:PNV) - 154x (Share price of $2.12 vs EPS of…

ByNick Sundich

ASX Biotech Investing In 2026: Investors Are More Aware Of The Hard Lessons, But Have Forgotten The Hidden Rewards Of It

Here are 7 ASX 200 Stocks Winning During The Iran War…And Aren’t In The Soaring Oil and Gas Space!

Here are 5 ASX Biotech Targets Amidst The $230bn Patent Cliff; And Which Big Pharma Companies Could Buy Them!

Is Telix Pharmaceuticals (ASX:TLX) Now Undervalued With Phase 3 China Clinical Success?

Telix Pharmaceuticals (ASX:TLX) Gets FDA Green Light to Resubmit — What Investors Should Know

ASX stocks in America: Here are 4 performing well and 4 performing poorly

Is the Market Missing Telix’s Long-Term Potential after 63% Revenue Growth?

ASX Health Care Stocks Under Trump: Who’ll Win and Who’ll Lose?

Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!

5 ASX stocks with the highest PE multiples and 5 ASX stocks with the lowest PE multiples!

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here